- Report
- November 2020
- 125 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,234GBP
- Report
- March 2019
- 168 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,234GBP
- Report
- October 2018
- 224 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,234GBP
- Report
- March 2021
- 64 Pages
India
- Report
- June 2019
- 71 Pages
Global
€2813EUR$2,950USD£2,396GBP
- Report
- September 2022
- 192 Pages
Global
From €3037EUR$3,185USD£2,587GBP
€4338EUR$4,550USD£3,696GBP
- Report
- November 2022
- 119 Pages
Global
From €4672EUR$4,900USD£3,980GBP
- Report
- April 2023
- 115 Pages
Global
From €4529EUR$4,750USD£3,858GBP
- Report
- August 2022
- 125 Pages
Global
From €4529EUR$4,750USD£3,858GBP
- Report
- March 2023
- 209 Pages
Global
From €3037EUR$3,185USD£2,587GBP
€4338EUR$4,550USD£3,696GBP
- Report
- August 2020
- 85 Pages
United States
From €2002EUR$2,100USD£1,706GBP
€2860EUR$3,000USD£2,437GBP
- Report
- March 2021
Global
From €3814EUR$4,000USD£3,249GBP
- Report
- July 2021
- 111 Pages
Global
From €4243EUR$4,450USD£3,615GBP
- Report
- December 2021
- 124 Pages
Global
From €4243EUR$4,450USD£3,615GBP
- Report
- April 2020
- 121 Pages
Global
From €3490EUR$3,660USD£2,973GBP
- Report
- June 2019
- 115 Pages
Global
From €4243EUR$4,450USD£3,615GBP
- Report
- October 2022
- 232 Pages
Global
From €3433EUR$3,600USD£2,924GBP
- Report
- October 2022
- 91 Pages
Middle East, Africa
From €1430EUR$1,500USD£1,218GBP
- Report
- October 2022
- 79 Pages
North America
From €1430EUR$1,500USD£1,218GBP
- Report
- October 2022
- 91 Pages
Asia Pacific
From €1430EUR$1,500USD£1,218GBP
Blood Plasma is a vital component of the pharmaceutical industry, used in the production of a variety of drugs and treatments. It is a component of the human body that is collected from healthy donors and used to create a range of products, including immunoglobulins, albumin, clotting factors, and other proteins. Plasma is also used to manufacture a variety of vaccines, including those for influenza, hepatitis, and rabies.
The demand for blood plasma has grown in recent years due to the increasing prevalence of chronic diseases and the need for more effective treatments. As a result, the market for blood plasma has become increasingly competitive, with a number of companies vying for a share of the market.
Some of the major players in the blood plasma market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. These companies are involved in the collection, processing, and distribution of blood plasma products, as well as the development of new treatments and therapies. Show Less Read more